You are here

antivirals

Atea sticks it out with failed COVID-19 antiviral but also raids Merck's store room for hepatitis C drug

Atea sticks it out with failed COVID-19 antiviral but also raids Merck's store room for hepatitis C drug

Fierce Biotech

Atea Pharmaceuticals

Flag link:

COVID-19 pill from Pfizer authorized by FDA in major pandemic milestone

COVID-19 pill from Pfizer authorized by FDA in major pandemic milestone

BioPharma Dive

Flag link:

Efficacy of Pfizer's Covid pill holds up in final analysis, reducing risk of hospitalization or death by almost 90%

Efficacy of Pfizer's Covid pill holds up in final analysis, reducing risk of hospitalization or death by almost 90%

Endpoints

clinical trials

Flag link:

How Pfizer developed a COVID pill in record time

How Pfizer developed a COVID pill in record time

NPR

drug development

Flag link:

Truepill preps launch of virtual COVID-19 service for oral antivirals

Truepill preps launch of virtual COVID-19 service for oral antivirals

Pharmaforum

Flag link:

FDA panel narrowly recommends authorization of first antiviral pill to treat Covid-19

FDA panel narrowly recommends authorization of first antiviral pill to treat Covid-19

Stat

Ridgeback Biotherapeutics

Flag link:

Pfizer boosts Paxlovid manufacturing capacity as Merck’s rival COVID pill hits surprise efficacy setback

Pfizer boosts Paxlovid manufacturing capacity as Merck’s rival COVID pill hits surprise efficacy setback

Fierce Pharma

drug manufacturing

Flag link:

New Merck study results raise questions about its COVID-19 pill

New Merck study results raise questions about its COVID-19 pill

BioPharma Dive

Flag link:

Covid antivirals could be pandemic game-changers. But Americans might struggle to access them

Covid antivirals could be pandemic game-changers. But Americans might struggle to access them

Stat

Flag link:

Gilead files first hepatitis delta therapy with FDA

Gilead files first hepatitis delta therapy with FDA

Pharmaforum

Gilead Sciences

hepatitis delta

Flag link:

Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?

Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?

Motley Fool

Flag link:

Pfizer inks $5.3B Paxlovid supply deal with US, adding to its huge pandemic revenue haul

Pfizer inks $5.3B Paxlovid supply deal with US, adding to its huge pandemic revenue haul

Fierce Pharma

government contracts

Flag link:

Pfizer, US in talks for 'multibillion-dollar' supply deal for COVID-19 pill

Pfizer, US in talks for 'multibillion-dollar' supply deal for COVID-19 pill

Fierce Pharma

Flag link:

Pfizer to file for emergency authorization Tuesday for its Covid-19 pill

Pfizer to file for emergency authorization Tuesday for its Covid-19 pill

Stat

Flag link:

Pfizer agrees to let other companies make its COVID-19 pill

Pfizer agrees to let other companies make its COVID-19 pill

AP

drug manufacturing

Flag link:

8 lingering questions about the new Covid pills from Merck and Pfizer

8 lingering questions about the new Covid pills from Merck and Pfizer

Stat

Flag link:

Merck's COVID-19 antiviral pill vs. Pfizer's: What's the same, what's different

Merck's COVID-19 antiviral pill vs. Pfizer's: What's the same, what's different

Beckers Hospital Review

Flag link:

US pays $1B to nearly double supply of Merck's COVID-19 pill

US pays $1B to nearly double supply of Merck's COVID-19 pill

BioPharma Dive

government contracts

Flag link:

Pfizer says its Covid pill with HIV drug cuts the risk of hospitalization or death by 89%

Pfizer says its Covid pill with HIV drug cuts the risk of hospitalization or death by 89%

CNBC

Flag link:

Merck’s Covid-19 antiviral pill receives first authorization in U.K.

Merck’s Covid-19 antiviral pill receives first authorization in U.K.

Stat

Flag link:

Pages